Log in to save to my catalogue

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal canc...

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal canc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3ddb855617e4e378193d6b8beddb2bb

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth

About this item

Full title

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2019-04, Vol.11 (4), p.1-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Excessive signaling through gp130, the shared receptor for the interleukin (IL)6 family of cytokines, is a common hallmark in solid malignancies and promotes their progression. Here, we established the
in vivo
utility of
bazedoxifene,
a steroid analog clinically approved for the treatment of osteoporosis, to suppress gp130‐dependent tum...

Alternative Titles

Full title

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f3ddb855617e4e378193d6b8beddb2bb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3ddb855617e4e378193d6b8beddb2bb

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.201809539

How to access this item